1200 related articles for article (PubMed ID: 15191803)
41. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
42. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
43. Non-dopaminergic neurons partly expressing dopaminergic phenotype: distribution in the brain, development and functional significance.
Ugrumov MV
J Chem Neuroanat; 2009 Dec; 38(4):241-56. PubMed ID: 19698780
[TBL] [Abstract][Full Text] [Related]
44. Pig xenografts to the immunocompetent rat brain: Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains.
Robichon R; Jaafar A; Terqui M; Brachet P; Peschanski M
Exp Neurol; 2005 Aug; 194(2):333-40. PubMed ID: 16022861
[TBL] [Abstract][Full Text] [Related]
45. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
46. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models.
Lopez-Real A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
Brain Res; 2003 Apr; 969(1-2):135-46. PubMed ID: 12676374
[TBL] [Abstract][Full Text] [Related]
47. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
48. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
Jackson D; Abercrombie ED; Zigmond MJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
[TBL] [Abstract][Full Text] [Related]
49. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
[TBL] [Abstract][Full Text] [Related]
50. Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter.
Arai A; Tomiyama M; Kannari K; Kimura T; Suzuki C; Watanabe M; Kawarabayashi T; Shen H; Shoji M
Synapse; 2008 Aug; 62(8):632-5. PubMed ID: 18509855
[TBL] [Abstract][Full Text] [Related]
51. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
52. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
[TBL] [Abstract][Full Text] [Related]
53. Dopaminergic neurons intrinsic to the striatum.
Huot P; Parent A
J Neurochem; 2007 Jun; 101(6):1441-7. PubMed ID: 17286588
[TBL] [Abstract][Full Text] [Related]
54. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
55. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.
Agrawal AK; Chaturvedi RK; Shukla S; Seth K; Chauhan S; Ahmad A; Seth PK
J Chem Neuroanat; 2004 Dec; 28(4):253-64. PubMed ID: 15531136
[TBL] [Abstract][Full Text] [Related]
56. Real-time dynamics of dopamine released from neuronal transplants in experimental Parkinson's disease.
Cragg SJ; Clarke DJ; Greenfield SA
Exp Neurol; 2000 Jul; 164(1):145-53. PubMed ID: 10877925
[TBL] [Abstract][Full Text] [Related]
57. Morphology and distribution of dopaminergic neurons intrinsic to the human striatum.
Cossette M; Lecomte F; Parent A
J Chem Neuroanat; 2005 Jan; 29(1):1-11. PubMed ID: 15589697
[TBL] [Abstract][Full Text] [Related]
58. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
Hahn M; Timmer M; Nikkhah G
J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
[TBL] [Abstract][Full Text] [Related]
59. [Fate of human fetal dopamine neurons transplanted into rhesus monkey model of Parkinson's disease: a tyrosine hydroxylase immunocytochemical study].
Jiang ZH; Liu ZG; Chen SD; Zhou WB; Cai J; Ni ZM; Zhou CF
Sheng Li Xue Bao; 1995 Feb; 47(1):31-7. PubMed ID: 7784896
[TBL] [Abstract][Full Text] [Related]
60. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
